23 results
·
15ms
·
Sources: EU EUDAMED, US FDA
Filters
Country: France
×
QUIES SAS
Manufacturer
🇫🇷 France·7 Basic UDI-DIs·9 Devices
Doculyse
Device
EU MDR
·
Eu Md Class 1
·QUIES SAS·On the market
Anti Snoring Lozenges C
Device
EU MDD
·
Eu Md Class 1
·QUIES SAS·On the market
Anti Snoring Lozenges HL
Device
EU MDD
·
Eu Md Class 1
·QUIES SAS·On the market
Anti Snoring Oral Spray
Device
EU MDD
·
Eu Md Class 1
·QUIES SAS·On the market
Anti Snoring Nasal Strips L
Device
EU MDR
·
Eu Md Class 1
·QUIES SAS·On the market·3 countries
Anti Snoring Nasal Strips SM
Device
EU MDR
·
Eu Md Class 1
·QUIES SAS·On the market
Anti Snoring Nasal Spray
Device
EU MDD
·
Eu Md Class 1
·QUIES SAS·On the market
Docuspray
Device
EU MDR
·
Eu Md Class 1
·QUIES SAS·On the market
Doculyse
Device
EU MDR
·
Eu Md Class 1
·QUIES SAS·On the market·6 countries
ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL)
FDA 510(k)
FDA Class 2
·Microbiology
ETEST Piperacillin/Tazobactam (P/T) (0.016/4-256/4 ug/mL)
FDA 510(k)
FDA Class 2
·Microbiology
Anti Snoring Lozenges
Basic UDI-DI
EU MDD
·
Eu Md Class 1
·QUIES SAS·1 device
Anti Snoring Lozenges
Basic UDI-DI
EU MDD
·
Eu Md Class 1
·QUIES SAS·1 device
Anti Snoring Oral Spray
Basic UDI-DI
EU MDD
·
Eu Md Class 1
·QUIES SAS·1 device
Anti Snoring Nasal Spray
Basic UDI-DI
EU MDD
·
Eu Md Class 1
·QUIES SAS·1 device
Docuspray
Basic UDI-DI
EU MDR
·
Eu Md Class 1
·QUIES SAS·1 device
Doculyse
Basic UDI-DI
EU MDR
·
Eu Md Class 1
·QUIES SAS·2 devices
Anti Snoring Nasal Strips
Basic UDI-DI
EU MDR
·
Eu Md Class 1
·QUIES SAS·2 devices
Etest¿ Piperacillin/tazobactam (4 ug/mL) PTc0.016-256-pack of 30 tests WW Etest¿ is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria.
FDA Enforcement
Class I
·Terminated·Biomerieux·December 30, 2015